Evidence map›Paper›PMID 35228578›Full record

ArticleScientific reports2022

A COVID-19 mortality prediction model for Korean patients using nationwide Korean disease control and prevention agency database.

Yongho Jee, Yi-Jun Kim, Jongmin Oh, Young-Ju Kim, Eun-Hee Ha, Inho Jo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Impact of COVID-19 Pandemic on Performance of Gastrointestinal Endoscopy.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yongho Jee *Advanced Biomedical Research Institute, Ewha Womans University Seoul Hospital, Seoul, Republic of Korea. jyongho@ewha.ac.kr.
Yi-Jun Kim *Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Jongmin OhDepartment of Environmental Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
Young-Ju KimDepartment of Obstetrics and Gynecology, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
Eun-Hee HaDepartment of Environmental Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
Inho JoDepartment of Molecular Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
Ewha Womans University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The experience of the early nationwide COVID-19 pandemic in South Korea led to an early shortage of medical resources. For efficient resource allocation, accurate prediction of the prognosis or mortality of confirmed patients is essential. Therefore, the aim of this study was to develop an accurate model for predicting COVID-19 mortality using epidemiolocal and clinical variables and for identifying a high-risk group of confirmed patients. Clinical and epidemiolocal variables of 4049 patients with confirmed COVID-19 between January 20, 2020 and April 30, 2020 collected by the Korean Disease Control and Prevention Agency were used. Among the 4049 total confirmed patients, 223 patients died, while 3826 patients were released from isolation. Patients who had the following risk factors showed significantly higher risk scores: age over 60 years, male sex, difficulty breathing, diabetes, cancer, dementia, change of consciousness, and hospitalization in the intensive care unit. High accuracy was shown for both the development set (n = 2467) and the validation set (n = 1582), with AUCs of 0.96 and 0.97, respectively. The prediction model developed in this study based on clinical features and epidemiological factors could be used for screening high-risk groups of patients and for evidence-based allocation of medical resources.

Indexed as

Databases, FactualHospitalizationIntensive Care UnitsModels, BiologicalSARS-CoV-2AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCOVID-19FemaleHumansInfantInfant, Newborn

Identifiers

PMID35228578
PMCPMC8885855
OpenAlexW4220661614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.